27-02-2025
Spyre Therapeutics: Q4 Earnings Snapshot
WALTHAM, Mass. — WALTHAM, Mass. — Spyre Therapeutics, Inc. (SYRE) on Thursday reported a loss of $56.3 million in its fourth quarter.
The Waltham, Massachusetts-based company said it had a loss of 81 cents per share.
The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.10 per share.
